DMT Encounters: What Alien Visions Teach Us
▼ Summary
– Anton Bilton participated in a 2022 clinical study at Imperial College London, the world’s first using extended DMT (DMTx) via an IV infusion to prolong the psychedelic experience.
– The DMTx concept was proposed to use target-controlled infusion technology to sustain the DMT state, allowing for longer study of phenomena like encounters with perceived nonhuman entities.
– A new retreat and research facility called Eleusis is launching on Bequia to study these entity encounters, described by neurobiologist Andrew Gallimore as a “SETI for the mind.”
– Eleusis will offer supervised DMTx sessions to guests alongside therapeutic practices, with medical screening to exclude individuals with certain health contraindications.
– The DMTx experience is marketed as a more controllable alternative to ayahuasca, as the IV dose can be adjusted or stopped, allowing effects to wear off quickly for safety.
A network of EEG sensors rested on Anton Bilton’s head, ready to chart the neural storm as a powerful substance entered his veins. He was about to undergo an infusion of dimethyltryptamine (DMT), a potent psychedelic known for its brief, intense effects. Despite his extensive history with such experiences, the familiar anxiety of the unknown remained. The moment of launch, he recalls, felt like an endless wait with his head on the block. Then, the transition was instantaneous, a violent launch into a dimension where he felt observed not just by the researchers in the room, but by a host of intelligent, non-human presences within the DMT space itself.
This was no ordinary journey. Bilton participated in a pioneering 2022 study at Imperial College London, part of the world’s first clinical research into “extended DMT,” or DMTx. The project was built on a proposal to use target-controlled intravenous infusion, a technology for maintaining steady anesthesia, to prolong the typically fleeting DMT state. His peak experience lasted around thirty minutes, far beyond the 10-15 minutes common with inhaled DMT. The study’s architect, neurobiologist Andrew Gallimore, is particularly focused on one enigmatic facet of these voyages: the widespread reports of encounters with seemingly autonomous, intelligent entities.
To delve deeper into this phenomenon, Gallimore and a team are launching a unique facility. On March 18, a new retreat and research center named Eleusis will open on the Caribbean island of Bequia. Its mission includes an ambitious goal: to establish sustained, two-way communication with these perceived beings. Gallimore describes the endeavor as a “SETI for the mind,” drawing a parallel to the search for extraterrestrial intelligence. The center takes its name from the ancient Greek site of the Eleusinian Mysteries, where initiates may have consumed a psychedelic brew.
While DMT remains a Schedule I controlled substance in the United States, it can be administered legally by licensed practitioners in Bequia. The Eleusis project will operate with two wings. The research division will be managed by Gallimore’s nonprofit, Noonautics, dedicated to exploring the frontiers of consciousness. The therapeutic side will be run by Charles Patti and Christina Thomas, who also operate a ketamine clinic in Florida. Although research on DMT’s therapeutic potential is less extensive than for psychedelics like psilocybin, early studies indicate promise for treating conditions including alcohol use disorder and major depression.
Guests at Eleusis, initially expecting around 30 visitors, can undergo DMTx sessions under medical supervision, integrated with complementary practices like breathwork and sound healing. All participants undergo rigorous screening to rule out individuals with specific cardiovascular issues, unmanaged psychiatric conditions, or problematic medication interactions. The experience is marketed as a more controlled and customizable alternative to ayahuasca, the traditional Amazonian brew containing DMT. An ayahuasca ceremony can last hours and often involves significant physical purging, which is traditionally viewed as part of the healing process. In contrast, the IV-based DMTx system allows for precise dose adjustment in real-time. If a participant becomes overwhelmed, the infusion can be stopped, and the effects typically subside within minutes.
The introductory package, priced at $9,500, covers a four-day stay with lodging, meals, and two extended DMTx sessions. This model aims to provide a structured environment for exploring profound states of consciousness while prioritizing safety and manageability, opening a new chapter in the formal study of humanity’s most mysterious inner voyages.
(Source: Wired)